Renewable energy vs. fossil fuels? It’s a false choice, says John Doerr

Renewable energy vs. fossil fuels? It’s a false choice, says John Doerr


As Russia’s war in Ukraine led to a spike in oil prices, energy shortages in Europe, and fears that the natural gas situation will get worse, there’s been a mounting backlash against renewable energy and the idea the world is prepared to function without fossil fuels.

What the world needs, according to John Doerr, chairman of venture capital firm Kleiner Perkins, is to get past the idea that it is one or the other.

“Now is the time to double down on renewable, free abundant energy sources that are not controlled by petro-dictators,” Doerr told CNBC’s Andrew Ross Sorkin from the Aspen Ideas Festival on Monday. “We are funding both sides of this war now.”

As a result of the current geopolitical situation, society should recognize the need for more sources of energy, and especially the need for more sources of clean energy. “It’s a false choice. We’ve got to do both,” Doerr said.

He rebutted the claim that it takes too long to develop renewable energy projects to deal with the world as it is today. “In 18 months you can deploy a new solar energy at scale. You cannot build a new natural gas liquefaction plant in that same period of time,” Doerr said.

He added, “The [International Energy Agency] says we don’t need to drill for any more hydrocarbons to meet the market need. We’ve got enough reserves. Develop those.”

Egypt’s abundance of solar and wind will “allow generation of renewable power at a highly competitive cost – and also serve as a a key enabler for green hydrogen production.

Ute Grabowsky | Photothek | Getty Images

Doerr, an early renewable energy investor, remains undeterred in his belief that “we are in an epic transition from a fossil fuel economy to a clean energy economy. It’s the largest economic development of our lifetime, it ranks up with the internet in terms of its impact. … It’s the best investment opportunity of our lifetime, but the road will be bumpy.”

In a separate interview at the Aspen Ideas Festival, Carlyle Group co-chairman and billionaire investor David Ruberstein told CNBC, “everybody wants more climate-friendly energy, of course, but it’s not easy to get there. What we’ve learned from the Russia-Ukraine war is that the world is still very heavily dependent on carbon energy, and right now, the world is scrambling to get more carbon energy.” He added, “The world is realizing you can’t go to carbon-neutral policies overnight; it will take a while.”

Doerr said the the most immediate change that can be made in the energy transition is not about creating new renewable technology or producing more hydrocarbons but to cut methane emissions leaks and wasted and flared methane. He said it “is a productive hydrocarbon, but we are just tossing it into the air like it is just a free and open sewer.”

He cited pledges from the large oil companies to put in place better and more effective caps and controls on their wells, as well as a project called Climate TRACE, which brings together 50 nonprofits to pool real-time data on emissions around the world, “like Google Earth, a kind of map you can track of carbon emissions and specifically focus on methane as a first and most potent gas.”

Disclosure: NBCUniversal News Group is the media partner of the Aspen Ideas Festival.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More